For evaluation of the specific in vivo binding of the ADAMTS4-specific probe, a fluorescein-labeled probe was administered intravenously in one ApoE−/− mouse 4 weeks after AAA induction and one sham-operated mouse. The gene discussed is ADAMTS4; the disease is triple-A syndrome.